November 02, 2026

Phapros (PEHA) Net Profit Surges 311.58% in Q3 2026, Driven by 15.07% Sales Growth

Phapros' delivered strong financial performance in the third quarter of 2026. Phapros' net profit surged 311.58%, more than quadrupling to IDR 31.60 billion, while sales grew 15.07% year-on-year (YoY) to IDR 786.57 billion....

See More
October 12, 2026

Phapros Distributes Healthcare Aid to Residents Affected by the Jatibarang Landfill Fire

Phapros has distributed healthcare assistance in the form of medicines, vitamins, first aid supplies, hygiene kits, and face masks to communities affected by the fire at the Jatibarang ...

See More
October 12, 2026

Phapros Takes Swift Action to Assist Communities Affected by Natural Disasters

Driven by its commitment to supporting disaster-affected communities, PT Phapros Tbk has taken swift action to distribute humanitarian assistance through its Phapros Peduli program. ...

See More
August 29, 2026

PEHA’s Net Profit Surges 511% in the First Half of 2026

PT Phapros Tbk (PEHA), part of the State-Owned Pharmaceutical Holding and Danantara Indonesia, continued to record positive financial performance growth in the first half of 2026...

See More
August 06, 2026

Phapros Supports Bakti Indonesia at Sam Poo Kong, Providing Community Health Services and Strengthening Diversity

Phapros is supporting the Bakti Indonesia: Social Charity Movement in Indonesia’s Diversity initiative organized by the Yayasan Bakti Keberagaman Indonesia (YBKI)...

See More
July 10, 2026

Commission VI of the DPR RI Reviews Phapros, Encourages the Strengthening of National Pharmaceutical Industry Independence

Phapros received a Specific Working Visit from Commission VI of the House of Representatives of the Republic of Indonesia (DPR RI) at the Simongan Factory, Semarang, on Friday (10/7). ...

See More